Metastatic Non-Small Cell Lung Cancer Withdrawn Phase 2 Trials for Nivolumab (DB09035)

Also known as: Metastatic untreated non small cell lung cancer / Non-Small Cell Lung Cancer Metastatic / Metastatic Non-small Cell Lung Cancer (NSCLC) / Metastatic Non-Small-Cell Lung Cancer / Lung cancer non-small cell stage IV / Non-small cell lung cancer stage IV

IndicationStatusPhase
DBCOND0043377 (Metastatic Non-Small Cell Lung Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02639234Vigilâ„¢ + Nivolumab in Advanced Non-Small Cell Lung CancerTreatment